Project Grant R18HS019248

This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $777,954 to the Icahn School of Medicine at Mount Sinai to conduct research on improving preconception cardiovascular health among adolescents. The key products and services to be delivered through this grant include: Constructing a school-based adolescent preconception cohort through data linkages to study the influence of school environments on cardiovascular risk...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $730,276 to the University of Texas Southwestern Medical Center under the Cardiovascular Diseases Research program (CFDA 93.837) on August 5, 2025, to conduct a Type 1 Hybrid Effectiveness-Implementation multicenter randomized controlled trial evaluating a polypill-based strategy for post-acute coronary syndrome (ACS) management. The five-year project, extending through July 31, 2030, addresses medication...

Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $1,289,113 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 15, 2025, with a completion date of May 31, 2029. The IPRISM (Imaging-Enhanced Prediction of Risk for Sudden Cardiac Death in HCM) study aims to develop an improved clinical tool for assessing sudden cardiac death (SCD) risk in pediatric...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Kaiser Foundation Hospitals $3.9M under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct the HIDDEN-ASCVD (Harnessing Artificial Intelligence and Deep Learning to Determine a Coronary Artery Calcium Estimate in Patients with No History of Atherosclerotic Cardiovascular Disease) Study. The project, initiated September 27, 2025, and concluding August 31, 2029, will deliver two primary...

Federal Project Grant Award Summary Rhode Island Hospital, a division of Lifespan Corporation, received a $195,696 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) awarded on September 8, 2025, with a completion date of June 30, 2030. The award funds the development and evaluation of the Active, Nourished, and Empowered Teens (ANET) program, a modular nutrition and fitness intervention designed to address...

Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Chicago a $275,196 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective September 23, 2025, with completion targeted for August 31, 2027. This research initiative examines the impact of adolescent reproductive health on cardiometabolic disease risk in young adult women by analyzing longitudinal data from the Pittsburgh Girls Study. The project evaluates three...

This $540,771 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will support research to develop a personalized, socially-aware stroke risk stratification tool for patients with atrial fibrillation (AF). The primary objectives are to: Discover new stroke risk factors for AF patients, incorporating social determinants of health (SDOH) data. An innovative Poisson Binomial Comorbidity (PBC) framework will be used to...

This Project Grant from the National Institute for Minority Health and Health Disparities, part of the Department of Health and Human Services National Institutes of Health, provides $769,755 to develop an unbiased machine learning tool for the prediction of acute coronary syndrome. The tool aims to minimize bias in predictions between patient demographic groups, as measured by equal opportunity difference and the Zemel statistic, to ensure machine learning algorithms do not exacerbate...

Federal Grant Award Summary Boston Children's Hospital received a $865,286 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, through June 30, 2029. The award funds the development of a high-resolution spatiotemporal lineage map of cardiac development—a comprehensive cellular atlas that traces the origin, differentiation pathways, and spatial distribution of cardiac progenitor...

Federal Project Grant Award Summary New York University School of Medicine received a $165,672 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 15, 2025, with an ultimate completion date of August 31, 2030. The award funds research aimed at increasing heart donor utilization in the United States by addressing barriers to adopting more liberal donor acceptance practices. The project...